What are digestive enzymes: How to test your patients levels
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that primarily works by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite
Across phenotypes, our data indicate an association between rs1800437 and tirzepatide treatment for both the vomiting and nausea phenotypes, and potentially constipation, but the variant does not seem to influence efficacy ( P = 0.73
Gastrointestinal (GI) side effects in patients, such as nausea, diarrhea, abdominal discomfort, or constipation, can occur with both drugs
Do I need lab work before starting medical weight loss
Safety Signals, Side Effects, and Muscle Loss The most discussed retatrutide vs tirzepatide side effects are gastrointestinal